The Global Prefilled Syringes Market Report by The Business Research Company covers prefilled syringes market’s drivers and restraints, prefilled syringes market size, major players, and the impact of COVID-19 on the prefilled syringes market.
The prefilled syringes market consists of sales of prefilled syringes by entities (organizations, sole traders, and partnerships) that manufacture disposable syringe supplied with already loaded medicine to be injected. The companies involved in the pre-filled syringes market are primarily engaged in the development, manufacturing, and marketing of prefilled syringes.
High demand for prefilled syringes to administer COVID-19 vaccines is expected to boost the prefilled syringes market during the forecast period.
The global prefilled syringes market is expected to grow from $5.78 billion in 2020 to $7.29 billion in 2021 at a compound annual growth rate (CAGR) of 20.74%. The exponential growth is mainly due to the companies catering to the growing demand for COVID-19 vaccines that require pre-filled syringes. The pre-filled syringes market is expected to reach $11.18 billion in 2025 at a CAGR of 11.30%.
Request A Sample For The Global Prefilled Syringes Market Report:
Some prefilled syringes market trends include companies increasingly investing in connected prefilled syringes, which allow healthcare professionals to track and access data. A connected prefilled syringe is a drug delivery device that can be connected to a smartphone that tracks data and reports to healthcare professionals accordingly. In 2020, Biocorp launched Injay, a connected prefilled syringe that is based on NFC technology wherein the technology helps in the transfer of data to a smartphone or specific transmitters, depending on specific use cases and environment. Similarly, in 2019, Credence MedSystems, developer of an injectable drug delivery technology, launched Connect auto-sensing injection system for any prefilled syringes. This enables healthcare professionals and self-injecting patients to collect data automatically and receive feedback for the dose.
Global prefilled syringes market segments include:
By Type: Conventional Prefilled Syringes, Safety Prefilled Syringes
By Material: Glass Prefilled Syringes, Plastic Prefilled Syringes
By Design: Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, Customized Prefilled Syringes
By Application: Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Others
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Europe accounts for the largest global prefilled syringes market share.
Read More On The Pre Filled Syringes Global Market Report 2021: COVID-19 Implications And Growth At:
The Pre Filled Syringes Global Market Report 2021: COVID-19 Implications And Growth is one of a series of new reports from The Business Research Company that provides prefilled syringes market overviews, analyzes and forecasts market size, share, prefilled syringes market players, prefilled syringes market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The prefilled syringes identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Pre Filled Syringes Global Market Report 2021: COVID-19 Implications And Growth from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc., Baxter International Inc., Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, Weigao Group, Novartis, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Amgen, Bayer AG, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffman-La Roche AG, AbbVie Inc., Owen Mumford, AptarGroup Inc., Medtronic, Abbott, Fresenius Kabi, Medpro, Mylan, Elcam Medical, YPSOMED, Oval Medical Technologies, and SHL Medical AG.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Prefilled Syringes Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Prefilled Syringes Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Prefilled Syringes Global Market Report 2021: